MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0010230
Frinze Laboratories Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹20.07 Cr
▲ 12% YoY
Net profit · FY 2025
₹36.64 Lakh
Net margin 1.8%
EBITDA · FY 2025
₹1.29 Cr
EBITDA margin 6.4%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹5.1 Cr
Secured borrowings
Company age
20 yrs
Est. 2006
Employees · EPFO
24
Provident fund records
About Frinze Laboratories Private Limited
Data last updated:
Frinze Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 08 September 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG2006PTC051094. Its GSTIN is 37AABCF0800B1ZH (Andhra Pradesh). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Uppala Venkata Bhaskara Rao (Managing Director) and Seetaram Srungaram.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.07 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹36.64 Lakh (net margin 1.8%) and EBITDA of ₹1.29 Cr (EBITDA margin 6.4%). Revenue has declined at a compounded annual rate (CAGR) of 45% over three years and 10% over five years.
The company has about 24 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹5.1 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
Frinze Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0010230). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website frinze.com.
Company details
CIN U24231TG2006PTC051094
Registration Number 051094
Incorporation Date 08 September 2006
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0010230
CIN history
Frinze Laboratories has one previous CIN (Corporate Identification Number): U24231AP2006PTC051094. The current CIN is U24231TG2006PTC051094, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG2006PTC051094 | Current |
| U24231AP2006PTC051094 | Previous |
Key People
Uppala Venkata Bhaskara Rao Managing Director Seetaram Srungaram Director Raveendra Velagapudi Director Recognitions & Rankings of Frinze Laboratories
Contact details
Frinze Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its website is frinze.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressH No.5 – 35/205/3B 1st Floor Sakthipuram Prashant Nagar Kukatpally Industrial Es, Tate, Hyderabad, Telangana, India – 500072
- IndustryPharma, API Manufacturers
To see the full contact details of Frinze Laboratories Private Limited, buy the company report.
Comprehensive company report
Frinze Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Frinze Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Frinze Laboratories Private Limited, buy the company report.
Financials of Frinze Laboratories Private Limited
FY 2025 filings availableFrinze Laboratories Private Limited reported revenue of ₹20.07 Cr (up 12% YoY) for FY 2025.
Revenue · FY 2025
₹20.07 Cr ▲ 12%
Net profit · FY 2025
₹36.64 Lakh margin 1.8%
EBITDA · FY 2025
₹1.29 Cr margin 6.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 45%
5 years · compounded
▼ 10%
EBITDA CAGR growth
1 year
▼ 24%
3 years · compounded
▲ 22%
5 years · compounded
▼ 10%
Revenue rose 12% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 10%. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.29 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹36.64 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.4% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Frinze Laboratories Private Limited, buy the company report.
Board of directors of Frinze Laboratories Private Limited
Frinze Laboratories has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Uppala Venkata Bhaskara Rao | Managing Director | 08 Sep 2006 | 20 Years 1 Months | Current |
| Seetaram Srungaram | Director | 24 Jan 2008 | 18 Years 9 Months | Current |
| Raveendra Velagapudi | Director | 01 Dec 2007 | 18 Years 11 Months | Current |
| Velagapudi Prameela | Director | 08 Sep 2006 | 20 Years 1 Months | Current |
Peer comparison
Frinze Laboratories Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Altis Finechem Private Limited | ₹20.53 Cr (FY 2025) | 62.0% | Prantij, Gujarat, India | |||
| Tosco Pharma Private Limited | ₹20.42 Cr (FY 2024) | 337.0% | Hyderabad, Telangana, India | |||
| Tesla Chemicals Private Limited | ₹20.24 Cr (FY 2025) | -18.0% | Panoli, Gujarat, India | |||
| Pharchem Private Limited | ₹20.2 Cr (FY 2024) | 0.0% | Boisar, Maharashtra, India | |||
| Suyog Life Sciences Private Limited | ₹20.09 Cr (FY 2025) | -1.0% | Ankleshwar, Gujarat, India | |||
| Frinze Laboratories Private Limitedthis company | ₹20.07 Cr (FY 2025) | ₹36.64 Lakh | 1.8% | 12.0% | 24 | Hyderabad, Telangana, India |
| Auro Laboratories Limited | ₹20.05 Cr (FY 2025) | -64.0% | Thane, Maharashtra, India | |||
| Asai Vishwa Speciality Chemicals Private Limited | ₹19.73 Cr (FY 2024) | -13.0% | Navi Mumbai, Maharashtra, India | |||
| Taaj Health Care Chemicals Private Limited | ₹19.54 Cr (FY 2024) | 233.0% | Thane, Maharashtra, India |
To see the full peer comparison of Frinze Laboratories Private Limited, buy the company report.
Auditor
Frinze Laboratories Private Limited is audited by M N REDDY & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M N REDDY & CO | FY 2022 | 010025S |
Shareholding
The shareholding of Frinze Laboratories Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Frinze Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Aug 2023 | 100772889 | Hdfc Bank Limited | ₹17.8 Lakh | Open | |
| 16 Jun 2023 | 100749925 | Hdfc Bank Limited | ₹30 Lakh | Open | |
| 31 Dec 2009 | 10198369 | Hdfc Bank Limited | ₹4.63 Cr | Open |
To see the full charge records of Frinze Laboratories Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Frinze Laboratories Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed against the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Appeal | Filed against the company by D.R. Organics Pvt. Ltd. | Pending |
| High Court, ANDHRAPRADESH | Appeal | Filed against the company by D.R. Organics Pvt. Ltd. | Disposed |
To see the full case history of Frinze Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Frinze Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Frinze Laboratories Private Limited has a workforce of 24 employees on its EPFO records as of Mar 21, 2024, across 1 active EPFO establishment.
Employee count
24
Active EPFO establishments
1
GST
Frinze Laboratories has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AABCF0800B1ZH | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Frinze Laboratories Private Limited, buy the company report.
Recent activity
Frinze Laboratories Private Limited has 6 board changes on record since 2006: 4 appointments and 2 cessations. The latest: Seetaram Srungaram was appointed as Director on 24 Jan 2008.
AGM
Frinze Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Frinze Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited of Rs. 4.63 Cr registered on 31 Dec 2009 with Charge ID 10198369 was modified on 09 Oct 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 100772889 was registered on 19 Aug 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100749925 was registered on 16 Jun 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.63 Cr with Charge ID 10198369 was registered on 31 Dec 2009.
Appointed
Seetaram Srungaram was appointed as Director.
Ceased
Uppala Venkata Bhaskara Rao ceased to be Director.
Appointed
Raveendra Velagapudi was appointed as Director.
Ceased
Raveendra Velagapudi ceased to be Additional Director.
Appointed
Uppala Venkata Bhaskara Rao was appointed as Managing Director.
Appointed
Velagapudi Prameela was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Frinze Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 08 September 2006 (20+ years old) and is registered under CIN U24231TG2006PTC051094.
Frinze Laboratories has 4 current directors:
- Uppala Venkata Bhaskara Rao - Managing Director
- Seetaram Srungaram - Director
- Raveendra Velagapudi - Director
- Velagapudi Prameela - Director
The latest financial statements of Frinze Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Frinze Laboratories is 37AABCF0800B1ZH, registered in Andhra Pradesh. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Frinze Laboratories is U24231TG2006PTC051094. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Frinze Laboratories has 2 court cases on record: 2 filed against it. 1 is pending.
Frinze Laboratories was incorporated on 08 September 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Frinze Laboratories by revenue are Altis Finechem Private Limited, Tosco Pharma Private Limited, Tesla Chemicals Private Limited, Pharchem Private Limited, Suyog Life Sciences Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Seetaram Srungaram was appointed as Director on 24 Jan 2008. Uppala Venkata Bhaskara Rao ceased to be Director on 24 Jan 2008. Raveendra Velagapudi was appointed as Director on 01 Dec 2007. Frinze Laboratories has 6 board changes on record in total.
Yes, Frinze Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0010230).
Frinze Laboratories can be reached through the website frinze.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages